Paragon 28, Inc. (FNA)
| Market Cap | 1.10B |
| Revenue (ttm) | 256.18M +18.4% |
| Net Income | -54.64M |
| EPS | -0.66 |
| Shares Out | 83.89M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,574,214 |
| Open | 13.01 |
| Previous Close | 13.09 |
| Day's Range | 13.07 - 13.11 |
| 52-Week Range | 4.65 - 13.13 |
| Beta | 1.47 |
| Analysts | Hold |
| Price Target | 14.50 (+10.77%) |
| Earnings Date | May 7, 2025 |
About FNA
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair ... [Read more]
Financial Performance
In 2024, Paragon 28's revenue was $256.18 million, an increase of 18.39% compared to the previous year's $216.39 million. Losses were -$54.64 million, -5.03% less than in 2023.
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for FNA stock is "Hold." The 12-month stock price target is $14.5, which is an increase of 10.77% from the latest price.
News
PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Paragon 28, Inc....
PARAGON 28 STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Paragon 28, Inc. (NYSE: FNA) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm for Additional Information
PHILADELPHIA, March 25, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Paragon 28, Inc. (“Paragon”) (NYSE: FNA) s...
Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation ...
Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announc...
Paragon 28 to Feature Several Recent Product Launches at The American Academy of Orthopaedic Surgeons Annual Conference
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation ...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA and TGI on Behalf of Shareholders
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and...
Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results
Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 diluted earnings per share were $2.31 F...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc.
NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed acquisi...
Zimmer Biomet to buy Paragon 28 for $1.1 billion
Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion.
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28
Demonstrates Zimmer Biomet's Commitment to Investing in Higher GrowthEnd-Markets, with Expansion into ~$5 Billion Foot and Ankle Segment Expected to Enhance Zimmer Biomet's Financial Profile; Immediat...
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a...
Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chai...
Paragon 28 Appoints Dave Demski to Board of Directors
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), (the “Company”) a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independen...
SHAREHOLDER REMINDER: Berger Montague Reminds Paragon 28 (NYSE: FNA) Investors of the November 29, 2024 Deadline
PHILADELPHIA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (N...
DEADLINE NEXT WEEK: Berger Montague Advises Paragon 28 (NYSE: FNA) Investors to Contact the Firm Before November 29, 2024
PHILADELPHIA, Nov. 23, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (N...